Bandello, Francesco

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 520

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

Grzybowski, A., Told, R., Sacu, S., Bandello, F., Moisseiev, E., Loewenstein, A., Schmidt-Erfurth, U., & on behalf of the Euretina Board (2018) · Ophthalmologica

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 297

Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration

Holz, F. G., Dugel, P. U., Weissgerber, G., Hamilton, R., Silva, R., Bandello, F., Larsen, M., Weichselberger, A., Wenzel, A., Schmidt, A., et al. (2016) · Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 184

Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset

Monés, J., Singh, R. P., Bandello, F., Souied, E., Liu, X., & Gale, R. (2020) · Ophthalmologica

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 110

Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration

Kunimoto, D., Yoon, Y. H., Wykoff, C. C., Chang, A., Khurana, R. N., Maturi, R. K., Agostini, H., Souied, E., Chow, D. R., Lotery, A. J., et al. (2020) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 91

A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration

Jackson, T. L., Slakter, J., Buyse, M., Wang, K., Dugel, P. U., Wykoff, C. C., Boyer, D. S., Gerometta, M., Baldwin, M. E., Price, C. F., et al. (2023) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 55

Brolucizumab and immunogenicity

Sharma, A., Kumar, N., Parachuri, N., Sharma, R., Bandello, F., Kuppermann, B. D., & Loewenstein, A. (2020) · Eye

Retinal Diseases and TreatmentsBiosimilars and Bioanalytical Methods

Cited by 51

Semaglutide and the risk of diabetic retinopathy—current perspective

Sharma, A., Parachuri, N., Kumar, N., Saboo, B., Tripathi, H. N., Kuppermann, B. D., & Bandello, F. (2022) · Eye

Retinal Diseases and TreatmentsDiabetes Treatment and Management

Cited by 43

A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma

Brambati, M., Giuffrè, C., Marchese, A., Bandello, F., Modorati, G. M., & Miserocchi, E. (2022) · European Journal of Ophthalmology

Ocular Diseases and Behçet’s SyndromeDrug-Induced Ocular Toxicity

Cited by 26

Association between Visual Acuity and Medical and Non-Medical Costs in Patients with Wet Age-Related Macular Degeneration in France, Germany and Italy

Bandello, F., Augustin, A., Sahel, J.-A., Benhaddi, H., Negrini, C., Hieke, K., & Berdeaux (2008) · Drugs & Aging

Retinal Diseases and TreatmentsHealth Systems, Economic Evaluations, Quality of Life

Cited by 19

Economic Aspects in the Management of Diabetic Macular Edema in Italy

Calabrò, G. E., Basile, M., Varano, M., Amore, F., Ricciardi, R., Bandello, F., & Cicchetti, A. (2022) · Frontiers in Public Health

Retinal Diseases and TreatmentsHealth Systems, Economic Evaluations, Quality of Life

Cited by 4